Alfa Biomed India Profile
Key Indicators
- Authorised Capital ₹ 68.10 Cr
- Paid Up Capital ₹ 27.84 Cr
- Company Age 9 Year, 14 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 28.61%
- Profit Growth 55.35%
- Ebitda 375.42%
- Net Worth 49.66%
- Total Assets 44.21%
About Alfa Biomed India
Alfa Biomed India Private Limited (ABIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 10 February 2016 (Nine years 14 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 68.10 Cr and a paid-up capital of Rs 27.84 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Alfa Biomed India Private Limited India is Rohit Kulkarni as COMPANY SECRETARY. Kiran Malekar and Dinesh Chandak serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999PN2016FTC158316
- Company No.
158316
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
10 Feb 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Alfa Biomed India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rohit Kulkarni | Company Secretary | 03-Oct-2024 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiran Malekar  | Director | 07-Jan-2021 | Current |
| Dinesh Chandak | Director | 23-Aug-2021 | Current |
Financial Performance of Alfa Biomed India.
Alfa Biomed India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.61% increase. The company also saw a substantial improvement in profitability, with a 55.35% increase in profit. The company's net worth Soared by an impressive increase of 49.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alfa Biomed India?
In 2023, Alfa Biomed India had a promoter holding of 27.87% and a public holding of 72.13%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Generic Healthcare Private LimitedKiran Malekar and Dinesh Chandak are mutual person
Adna FoundationKiran Malekar and Dinesh Chandak are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alfa Biomed India?
Alfa Biomed India has a workforce of 171 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alfa Biomed India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alfa Biomed India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
